| Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial D Currow, S Louw, P McCloud, B Fazekas, J Plummer, CF McDonald, ... Thorax 75 (1), 50-56, 2020 | 94 | 2020 |
| Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial DC Currow, M Ekström, S Louw, J Hill, B Fazekas, K Clark, PM Davidson, ... European Respiratory Journal 53 (1), 2019 | 46 | 2019 |
| Controlled-release oxycodone vs. placebo in the treatment of chronic breathlessness—a multisite randomized placebo controlled trial DH Ferreira, S Louw, P McCloud, B Fazekas, CF McDonald, MR Agar, ... Journal of pain and symptom management 59 (3), 581-589, 2020 | 39 | 2020 |
| A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer DC Currow, P Glare, S Louw, P Martin, K Clark, B Fazekas, MR Agar Scientific reports 11 (1), 2421, 2021 | 33 | 2021 |
| Prescribed water intake in autosomal dominant polycystic kidney disease GK Rangan, ATY Wong, A Munt, JQJ Zhang, S Saravanabavan, S Louw, ... NEJM evidence 1 (1), EVIDoa2100021, 2022 | 31 | 2022 |
| A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic … D Currow, GJ Watts, M Johnson, CF McDonald, JO Miners, AA Somogyi, ... BMJ open 7 (7), e018100, 2017 | 30 | 2017 |
| Survival outcomes of elderly patients with glioblastoma multiforme in their 75th year or older treated with adjuvant therapy G Harris, D Jayamanne, H Wheeler, C Gzell, M Kastelan, G Schembri, ... International Journal of Radiation Oncology* Biology* Physics 98 (4), 802-810, 2017 | 29 | 2017 |
| Effect of regular, low-dose, extended-release morphine on chronic breathlessness in chronic obstructive pulmonary disease: the BEAMS randomized clinical trial M Ekström, D Ferreira, S Chang, S Louw, MJ Johnson, DJ Eckert, ... Jama 328 (20), 2022 | 28 | 2022 |
| A randomized, double‐blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already … DC Currow, K Clark, S Louw, B Fazekas, A Greene, CR Sanderson European Journal of Pain 24 (5), 983-991, 2020 | 16 | 2020 |
| Australian National Palliative Care Clinical Studies Collaborative (PaCCSC). Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind … D Currow, S Louw, P McCloud, B Fazekas, J Plummer, CF McDonald, ... Thorax 75 (1), 50-56, 2020 | 13 | 2020 |
| Australian National Palliative Care Clinical Studies Collaborative (PaCCSC). Controlled-release oxycodone vs. placebo in the treatment of chronic breathlessness-a multisite … DH Ferreira, S Louw, P McCloud, B Fazekas, CF McDonald, MR Agar J Pain Symptom Manage 59 (3), 581-589, 2020 | 8 | 2020 |
| Australian National Palliative Care Clinical Studies Collaborative. Effect of regular, low-dose, extended-release morphine on chronic breathlessness in chronic obstructive … M Ekström, D Ferreira, S Chang, S Louw, MJ Johnson, DJ Eckert, ... JAMA 328 (20), 2022-32, 2022 | 7 | 2022 |
| Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial DC Currow, T Hunt, S Louw, D Eckert, P Allcroft, THM To, A Greene, ... ERJ Open Research 5 (4), 2019 | 6 | 2019 |
| Acute epithelial toxicity is prognostic for improved prostate cancer response to radiation therapy: A retrospective, multicenter, cohort study T Eade, A Choudhury, A Pollack, M Abramowitz, FM Chinea, L Guo, ... International Journal of Radiation Oncology* Biology* Physics 101 (4), 957-963, 2018 | 6 | 2018 |
| Regular extended release morphine for chronic breathlessness: a multi-centre double-blind RCT D Currow, S Louw, P Mccloud, B Fazekas, J Plummer, C Mcdonald, ... European Respiratory Journal 52 (suppl 62), 2018 | 5 | 2018 |
| Treating anorexia in people with advanced cancer. a randomised, double blind, controlled trial of megestrol acetate, dexamethasone or placebo. DC Currow, PA Glare, G Watts, S Louw, P Martin, K Clark, B Fazekas, ... Journal of Clinical Oncology 36 (15_suppl), 10020-10020, 2018 | 4 | 2018 |
| Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi‐centre Australian study K Tymms, A Kelly, P Bird, H Griffiths, J De Jager, G Littlejohn, S Louw, ... International Journal of Rheumatic Diseases 21 (2), 510-516, 2018 | 3 | 2018 |
| Contemporary salvage post prostatectomy radiotherapy: early implementation improves biochemical control A Kneebone, G Hruby, G Harris, K Rasiah, J Vass, D Whalley, P McCloud, ... Journal of Medical Imaging and Radiation Oncology 62 (2), 240-247, 2018 | 2 | 2018 |
| THE PARA STUDY: A MULTI-CENTRE, CROSS-SECTIONAL STUDY OF PATIENTS TREATED WITH CASPAR-VALIDATED PSORIATIC ARTHRITIS IN AUSTRALIA D Nicholls, A Nakayama, H Griffiths, G Littlejohn, P Bird, L Roberts, ... INTERNAL MEDICINE JOURNAL 46, 38-38, 2016 | 2 | 2016 |
| The timing of salvage postprostatectomy radiation therapy: waiting for the PSA to climb above 0.2 May compromise outcome G Harris, A Kneebone, DM Whalley, P McCloud, S Thompson, L Guo, ... International Journal of Radiation Oncology, Biology, Physics 93 (3), E206-E207, 2015 | 1 | 2015 |
